Study finds a subset of artificial heart patients can regenerate heart muscle

De­moc­rats on the House over­sight com­mit­tee are ask­ing man­u­fac­tur­ers of sev­er­al drugs in short sup­ply — in­clud­ing an­tibi­otics, can­cer drugs and AD­HD med­ica­tions — to

Japan­ese drug­mak­er Ky­owa Kirin is ac­quir­ing most of the com­mer­cial rights for Ku­ra On­col­o­gy’s tar­get­ed leukemia treat­ment, pay­ing $330 mil­lion up­front and al­most $1.2 bil­lion